Pacific Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10M Sell
38,039
-229
-0.6% -$58.7K 4.38% 4
2026
Q2
$9.6M Sell
38,268
-184
-0.5% -$39.6K 4.27% 5
2026
Q1
$8.36M Sell
38,452
-275
-0.7% -$61K 4.5% 5
2025
Q4
$8.85M Sell
38,727
-785
-2% -$179K 4.11% 6
2025
Q3
$9.15M Hold
39,512
– – 4.61% 5
2025
Q2
$7.33M Sell
39,512
-137
-0.3% -$25.5K 3.62% 8
2025
Q1
$8.31M Sell
39,649
-237
-0.6% -$46.1K 4.57% 6
2024
Q4
$7.09M Sell
39,886
-370
-0.9% -$68K 3.75% 7
2024
Q3
$7.95M Sell
40,256
-142
-0.4% -$26.5K 3.7% 7
2024
Q2
$6.93M Buy
40,398
+727
+2% +$120K 3.53% 6
2024
Q1
$6.15M Hold
39,671
– – 3.51% 7
2023
Q4
$6.15M Buy
39,671
+99
+0.3% +$14.4K 3.51% 7
2023
Q3
$5.9M Buy
39,572
+378
+1% +$55.5K 3.88% 6
2023
Q2
$5.28M Sell
39,194
-2,564
-6% -$376K 3.43% 8
2023
Q1
$6.66M Buy
41,758
+408
+1% +$62.4K 4.27% 6
2022
Q4
$6.68M Buy
41,350
+544
+1% +$83.4K 4.91% 7
2022
Q3
$5.48M Buy
+40,806
New +$5.86M 4.86% 7

Other funds holding ABBV

Pacific Wealth Management's ABBV Position: Q3 2026 in Review

Pacific Wealth Management reduced its AbbVie (ABBV) stake by 0.6% in Q3 2026, selling an estimated $58.7K and leaving 38,039 shares worth $10M. The position accounts for 4.38% of the portfolio, ranked #4.

Pacific Wealth Management first reported a position in ABBV in Q3 2022 and has held it in 17 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Pacific Wealth Management held 38,039 shares of AbbVie worth $10M as of Q3 2026.
  • Pacific Wealth Management sold 229 AbbVie shares in Q3 2026, an estimated $58.7K.
  • AbbVie made up 4.38% of Pacific Wealth Management's portfolio in Q3 2026, its #4 holding.
  • Pacific Wealth Management first reported a position in AbbVie in Q3 2022 and has held it in 17 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Pacific Wealth Management's 13F filing for Q3 2026, filed 5 Oct 2026.